Ensign Peak Advisors, Inc Curis Inc Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $47,355 - $105,165	-20,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.45 - $8.09 $91,225 - $165,845	20,500 New	20,500 $98,000
Q2 2021 Aug 13, 2021	SELL	$7.45 - $16.27 $602,205 - $1.32 Million	-80,833 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$8.78 - $12.8 $709,713 - $1.03 Million	80,833 New	80,833 $915,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.